Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › CHOP

CHOP

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of CHOP

2 trials tracked of CHOP: 1 in phase 3 or 4.

2Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 1
  1. Phase 3 A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma Completed
  2. Phase 2 Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Baseline anti-HBc positivity does not impact 3-year PFS or OS in HBsAg-negative DLBCL
Gastroenterology RCT
Baseline anti-HBc positivity does not impact 3-year PFS or OS in HBsAg-negative DLBCL Hepatitis B history does not impact lymphoma treatment outcomes
This supplementary analysis of a Phase II/III trial involved 405 patients with HBsAg-negative diffuse large B-cell lymphoma treated with rit…
Patients with a history of hepatitis B and certain types of lymphoma saw the same survival rates as those without it.
Nov 2, 2026